Texas Insurance Code - INS § 1372.001. Definitions

(A) gene mutations;  and

(B) protein expression.

(A) single-analyte tests;

(B) multiplex panel tests;  and

(C) whole genome sequencing.

(A) address specific clinical circumstances based on the best available evidence for the purpose of optimizing clinical care outcomes;  and

(B) are developed by an independent, multidisciplinary panel of experts that uses a transparent methodology and reporting structure and is subject to a conflict of interest policy.

(A) establish a standard of care informed by a systematic review of evidence and an assessment of the benefits and costs of alternative care options;

(B) include recommendations intended to optimize patient care;  and

(C) are developed by an independent organization or medical professional society that uses a transparent methodology and reporting structure and is subject to a conflict of interest policy.